Your Unread Messages in Oncology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Centromere protein A is a prognostic biomarker for lung adenocarcinoma
Smartest Doc Challenge
MDLinx
Is there both a PFS and OS benefit for patients undergoing autologous transplantation?
Steve Smith
Executive Editor, MDLinx
3,000+ new jobs posted this week
1 Lenalidomide maintenance after stem-cell transplantation for multiple myeloma New England Journal of Medicine, May 17, 2012 Clinical Article
2 Long-term results of screening with magnetic resonance imaging in women with BRCA mutations British Journal of Cancer, May 17, 2012
3 The relationship between vitamin D and chemotherapy-induced toxicity: A pilot study British Journal of Cancer, May 17, 2012 Clinical Article
4 Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I trial Journal of Clinical Oncology, May 17, 2012 Clinical Article
5 Human epidermal growth factor receptor 2 status and interval breast cancer in a population-based cancer registry study Journal of Clinical Oncology, May 17, 2012
6 Influence of sex on the survival of patients with esophageal cancer Journal of Clinical Oncology, May 17, 2012 Clinical Article
7 Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: The MMVAR/IFM 2005-04 randomized phase III trial from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Journal of Clinical Oncology, May 17, 2012 Clinical Article
8 Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors Journal of Clinical Oncology, May 17, 2012
9 Updated analysis of SWOG-directed Intergroup Study 0116: A phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection Journal of Clinical Oncology, May 17, 2012
10 Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non-muscle-invasive bladder cancer: Results from a prospective randomized phase III trial Journal of Clinical Oncology, May 17, 2012 Clinical Article
11 Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome Journal of Clinical Oncology, May 17, 2012 Clinical Article
12 Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial The Lancet - Early Online Publication, May 17, 2012 Clinical Article
13 Adoption of Gene Expression Profile Testing and Association With Use of Chemotherapy Among Women With Breast Cancer Journal of Clinical Oncology, May 17, 2012
14 Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid Neoplasms Journal of Clinical Oncology, May 17, 2012
15 Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells British Journal of Haematology, May 17, 2012
16 Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma BJU International, May 17, 2012
17 Percutaneous cryoablation of solitary sporadic renal cell carcinomas BJU International, May 17, 2012 Clinical Article
18 Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit Melanoma Clinical Cancer Research, May 17, 2012 Clinical Article
19 Development of a human monoclonal antibody for potential therapy of CD27-expressing lymphoma and leukemia Clinical Cancer Research, May 17, 2012
20 Serum sex steroids depict a nonlinear u-shaped association with high-risk prostate cancer at radical prostatectomy Clinical Cancer Research, May 17, 2012
New Topics in Oncology
See All >>1 Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP Protocol B-24 Journal of Clinical Oncology, April 9, 2012
2 The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal Journal of Gastrointestinal Oncology, April 16, 2012 Free full text
3 Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: Results of the randomized phase III CHER-LB study Journal of Clinical Oncology, April 12, 2012
4 Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer European Journal of Cancer, April 2, 2012
5 Metformin use is associated with better survival of diabetic patients with pancreatic cancer Clinical Cancer Research, April 4, 2012
6 Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study The Lancet, April 24, 2012
7 Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials The Lancet Oncology - Online First, March 22, 2012
8 Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data Journal of Clinical Oncology, April 5, 2012
9 Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer Cancer, April 6, 2012
10 Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial The Lancet Oncology - Online First, March 28, 2012
11 Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial The Lancet - Early Online Publication, April 5, 2012
12 The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus International Journal of Cancer, April 26, 2012
13 Infectious complications of chemotherapy in clinically aggressive mature B and T cell lymphomas European Journal of Internal Medicine , April 3, 2012
14 Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer JAMA, April 19, 2012
15 Association between tamoxifen treatment and diabetes Cancer, April 16, 2012
16 The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer International Journal of Cancer, April 23, 2012
17 Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcome European Journal of Cancer, April 11, 2012
18 Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix International Journal of Cancer, April 18, 2012
19 Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial The Lancet Oncology - Online First, April 20, 2012
20 Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C) Journal of Clinical Oncology, April 9, 2012
Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close